Luke Sergott
Stock Analyst at Barclays
(4.73)
# 707
Out of 5,043 analysts
788
Total ratings
49.3%
Success rate
13.6%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Reiterated: Buy | $175 → $195 | $170.54 | +14.34% | 35 | Oct 7, 2026 | |
| AVTR Avantor | Reiterated: Sell | $13 → $15 | $15.67 | -4.28% | 46 | Oct 7, 2026 | |
| BRKR Bruker | Reiterated: Buy | $58 → $70 | $58.84 | +18.97% | 21 | Oct 7, 2026 | |
| CERT Certara | Reiterated: Hold | $7.5 → $9 | $9.13 | -1.42% | 37 | Oct 7, 2026 | |
| DGX Quest Diagnostics | Reiterated: Buy | $250 → $260 | $230.97 | +12.57% | 21 | Oct 7, 2026 | |
| DHR Danaher | Reiterated: Buy | $230 → $255 | $219.81 | +16.01% | 48 | Oct 7, 2026 | |
| GH Guardant Health | Reiterated: Buy | $200 → $220 | $167.47 | +31.37% | 21 | Oct 7, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Hold | $175 | $164.17 | +6.60% | 42 | Oct 7, 2026 | |
| ILMN Illumina | Reiterated: Sell | $160 → $200 | $278.17 | -28.10% | 51 | Oct 7, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $275 → $300 | $259.88 | +15.44% | 50 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 | $312.15 | +5.72% | 18 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $450 → $625 | $612.05 | +2.12% | 11 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,575 → $1,700 | $1,549.99 | +9.68% | 11 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 → $475 | $400.71 | +18.54% | 17 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.25 | $2.33 | -46.35% | 28 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 → $225 | $173.88 | +29.40% | 13 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $115 → $160 | $154.18 | +3.77% | 35 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $18.06 | +21.82% | 44 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 → $750 | $658.02 | +13.98% | 47 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 → $215 | $159.78 | +34.56% | 42 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $110 | $80.65 | +36.39% | 36 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $460 → $500 | $433.77 | +15.27% | 36 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $440 | $366.00 | +20.22% | 12 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $23 | $20.84 | +10.36% | 23 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $55 | $45.38 | +21.20% | 19 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 → $330 | $301.79 | +9.35% | 21 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 → $42 | $5.28 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 | $229.26 | n/a | 1 | Jan 18, 2023 |
Agilent Technologies
Oct 7, 2026
Reiterated: Buy
Price Target: $175 → $195
Current: $170.54
Upside: +14.34%
Avantor
Oct 7, 2026
Reiterated: Sell
Price Target: $13 → $15
Current: $15.67
Upside: -4.28%
Bruker
Oct 7, 2026
Reiterated: Buy
Price Target: $58 → $70
Current: $58.84
Upside: +18.97%
Certara
Oct 7, 2026
Reiterated: Hold
Price Target: $7.5 → $9
Current: $9.13
Upside: -1.42%
Quest Diagnostics
Oct 7, 2026
Reiterated: Buy
Price Target: $250 → $260
Current: $230.97
Upside: +12.57%
Danaher
Oct 7, 2026
Reiterated: Buy
Price Target: $230 → $255
Current: $219.81
Upside: +16.01%
Guardant Health
Oct 7, 2026
Reiterated: Buy
Price Target: $200 → $220
Current: $167.47
Upside: +31.37%
ICON Public Limited Company
Oct 7, 2026
Reiterated: Hold
Price Target: $175
Current: $164.17
Upside: +6.60%
Illumina
Oct 7, 2026
Reiterated: Sell
Price Target: $160 → $200
Current: $278.17
Upside: -28.10%
IQVIA Holdings
Oct 7, 2026
Reiterated: Buy
Price Target: $275 → $300
Current: $259.88
Upside: +15.44%
Oct 7, 2026
Reiterated: Hold
Price Target: $330
Current: $312.15
Upside: +5.72%
Oct 7, 2026
Reiterated: Hold
Price Target: $450 → $625
Current: $612.05
Upside: +2.12%
Oct 7, 2026
Reiterated: Buy
Price Target: $1,575 → $1,700
Current: $1,549.99
Upside: +9.68%
Oct 7, 2026
Reiterated: Buy
Price Target: $340 → $475
Current: $400.71
Upside: +18.54%
Oct 7, 2026
Reiterated: Sell
Price Target: $1.25
Current: $2.33
Upside: -46.35%
Oct 7, 2026
Reiterated: Buy
Price Target: $175 → $225
Current: $173.88
Upside: +29.40%
Oct 7, 2026
Reiterated: Hold
Price Target: $115 → $160
Current: $154.18
Upside: +3.77%
Oct 7, 2026
Reiterated: Buy
Price Target: $22
Current: $18.06
Upside: +21.82%
Oct 7, 2026
Reiterated: Buy
Price Target: $650 → $750
Current: $658.02
Upside: +13.98%
Oct 7, 2026
Reiterated: Buy
Price Target: $112 → $215
Current: $159.78
Upside: +34.56%
Oct 7, 2026
Reiterated: Buy
Price Target: $52 → $110
Current: $80.65
Upside: +36.39%
Oct 7, 2026
Reiterated: Buy
Price Target: $460 → $500
Current: $433.77
Upside: +15.27%
Oct 7, 2026
Reiterated: Buy
Price Target: $400 → $440
Current: $366.00
Upside: +20.22%
Oct 6, 2026
Upgraded: Buy
Price Target: $22 → $23
Current: $20.84
Upside: +10.36%
Oct 6, 2026
Upgraded: Buy
Price Target: $40 → $55
Current: $45.38
Upside: +21.20%
Sep 24, 2026
Reiterated: Buy
Price Target: $300 → $330
Current: $301.79
Upside: +9.35%
Jun 12, 2023
Reiterated: Hold
Price Target: $35 → $42
Current: $5.28
Upside: n/a
Jan 18, 2023
Rated: Buy
Price Target: $200
Current: $229.26
Upside: n/a